Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Jazz Pharmaceuticals plc Director's Dealing 2014

Mar 14, 2014

30751_dirs_2014-03-14_324c60cd-f910-47c6-8d78-88abdff13d32.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-03-09

Reporting Person: Young Matthew P. (SVP & CFO)

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 16500 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Nonstatutory Stock Option (right to buy) $58.72 2023-05-02 Ordinary Shares (17192) Direct
Incentive Stock Option (right to buy) $58.72 2023-05-02 Ordinary Shares (6808) Direct
Nonstatutory Stock Option (right to buy) $166.62 2024-02-26 Ordinary Shares (8625) Direct
Incentive Stock Option (right to buy) $166.62 2024-02-26 Ordinary Shares (375) Direct

Footnotes

F1: Consists of 12,000 restricted stock units granted on May 3, 2013 and 4,500 restricted stock united granted on February 27, 2014, both grants are pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. The 12,000 restricted stock units vest in four equal annual installments on the anniversary of the grant date, May 3, 2013. The 4,500 restricted stock units vest in four equal annual installments on the anniversary of the grant date, February 27, 2014.

F2: These two options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these two options vest over four years measured from the vesting commencement date, April 22, 2013, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter.

F3: These two options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these two options vest over four years measured from the grant date, February 27, 2014, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.